High serum levels of HMGB1 have also been observed in non-diabetic patients with CAD [13]; monitoring of HMGB1 could indirectly aid in discriminating plaque characteristics, as this could allow us to detect non-calcified plaques [14]. This evidence concerns the gene HMGB1 and coronary artery disorder.